Clinical Trial Update: Cardiovascular Risk Factor Management in HIV Infection [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating cardiovascular risk factor management in HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Dyslipidemia
• HIV Infection
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Coronary Heart Disease, Dyslipidemia | Phase 4 | Status: COMPLETED